The Non-Classical MAP Kinase ERK3 Controls T Cell Activation

被引:19
|
作者
Marquis, Miriam [1 ,2 ]
Boulet, Salix [1 ]
Mathien, Simon [5 ]
Rousseau, Justine [3 ,5 ]
Thebault, Pamela [1 ]
Daudelin, Francois [1 ]
Rooney, Julie [1 ]
Turgeon, Benjamin [3 ,5 ]
Beauchamp, Claudine [1 ]
Meloche, Sylvain [3 ,5 ]
Labrecque, Nathalie [1 ,2 ,4 ]
机构
[1] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada
[2] Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada
[3] Univ Montreal, Dept Pharmacol & Mol Biol, Quebec City, PQ, Canada
[4] Univ Montreal, Dept Med, Quebec City, PQ, Canada
[5] Univ Montreal, Inst Res Immunol & Canc, Quebec City, PQ, Canada
来源
PLOS ONE | 2014年 / 9卷 / 01期
关键词
SIGNAL-REGULATED KINASES; HUMAN CDC14A PHOSPHATASE; DIFFERENTIAL REGULATION; CHROMOSOME SEGREGATION; EXPRESSION; MK5; PHOSPHORYLATION; PROLIFERATION; RECEPTOR; MEMORY;
D O I
10.1371/journal.pone.0086681
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The classical mitogen-activated protein kinases (MAPKs) ERK1 and ERK2 are activated upon stimulation of cells with a broad range of extracellular signals (including antigens) allowing cellular responses to occur. ERK3 is an atypical member of the MAPK family with highest homology to ERK1/2. Therefore, we evaluated the role of ERK3 in mature T cell response. Mouse resting T cells do not transcribe ERK3 but its expression is induced in both CD4(+) and CD8(+) T cells following T cell receptor (TCR)-induced T cell activation. This induction of ERK3 expression in T lymphocytes requires activation of the classical MAPK ERK1 and ERK2. Moreover, ERK3 protein is phosphorylated and associates with MK5 in activated primary T cells. We show that ERK3-deficient T cells have a decreased proliferation rate and are impaired in cytokine secretion following in vitro stimulation with low dose of anti-CD3 antibodies. Our findings identify the atypical MAPK ERK3 as a new and important regulator of TCR-induced T cell activation.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering
    Sipeki, S
    Bander, E
    Buday, L
    Farkas, G
    Bácsy, E
    Ways, DK
    Faragó, A
    CELLULAR SIGNALLING, 1999, 11 (12) : 885 - 890
  • [42] T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens
    Thierse, HJ
    Gamerdinger, K
    Junkes, C
    Guerreiro, N
    Weltzien, HU
    TOXICOLOGY, 2005, 209 (02) : 101 - 107
  • [43] Activation of the gall gene of yeast by pairs of 'non-classical' activators
    Cheng, JX
    Gandolfi, M
    Ptashne, M
    CURRENT BIOLOGY, 2004, 14 (18) : 1675 - 1679
  • [44] Non-classical applications of chemical analysis based on nuclear activation
    M. Grdeń
    Journal of Radioanalytical and Nuclear Chemistry, 2020, 323 : 677 - 714
  • [46] Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation
    Moes, Bastien
    Rudd, Christopher E.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2025, : 557 - 558
  • [47] Non-classical activation of GLI1 as a therapeutic target for squamous cell lung cancer
    Kasiri, Sahba
    Shao, Chunli
    Chen, Baozhi
    Wilson, Alexandra
    Yenerall, Paul
    Timmons, Brenda
    Dospoy, Patrick
    Hight, Suzie
    Girard, Luc
    Tian, Hui
    Behrens, Carmen
    Wistuba, Ignacio
    Gazdar, Adi
    Kim, James
    CANCER RESEARCH, 2016, 76
  • [48] Non-classical Organ Involvement in Giant Cell Arteritis
    Narvaez-Garcia, Javier
    Vidal, Paola
    Maymo, Pol
    Palacios, Judith
    Aguilar Coll, Marti
    Roig Kim, Monserrat
    De Daniel, Laia
    Miquel Nolla, Joan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1571 - 1573
  • [49] The non-classical MHC MICA antigens stimulate T cell expansion and cell-mediated cytotoxicity
    Zhang, YZ
    Stastny, P
    HUMAN IMMUNOLOGY, 2005, 66 : S50 - S50
  • [50] Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation
    Santos, L. L.
    Dacumos, A.
    Yamana, J.
    Sharma, L.
    Morand, E. F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 152 (02): : 372 - 380